| Financial Year |
March 31 2023 |
| Monetary Funds |
22,788,364.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,600,000.00 |
| Accounts Receivable |
1,850,811,550.62 |
| Advances to Suppliers |
13,596,405.09 |
| Other Receivables |
208,407,398.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
82,923,232.24 |
| Dividend Receivable |
-- |
| Inventories |
115,351,941.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
97,271,911.79 |
| Total Current Assets |
2,623,752,839.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
21,530,135.95 |
| Fixed Assetes |
12,955,670.97 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,042,785.36 |
| R&D expenses |
-- |
| Goodwill |
82,669,428.69 |
| Long-Term Deferred and Prepaid Expenses |
1,684,481.65 |
| Deferred Income Tax Assets |
62,155,778.37 |
| Other Non-Current Assets |
320,855,036.11 |
| Sub-Total of Non-Current Assets |
849,006,593.07 |
| Total Assets |
3,472,759,432.96 |
| Short-Term Loans |
165,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
965,361,155.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,911,655.20 |
| Taxes Payable |
51,190,399.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,071,117,198.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,813,870.64 |
| Other Current Liabilities |
178,001,555.80 |
| Sub-Total of Current Liabilities |
2,543,769,442.64 |
| Long-term Loans |
37,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
17,112,751.17 |
| Deferred Income Tax Liabilities |
4,653,677.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
67,695,482.73 |
| Total Liabilities |
2,611,464,925.37 |
| Paid-In Capital(Or Share Stock) |
1,058,692,292.00 |
| Capital Surplus |
1,967,719,170.10 |
| Surplus Reserve |
8,592,788.79 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,356,796,849.60 |
| Minority Stockholder's Interest |
183,087,106.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
678,207,401.29 |
| Owner's Equity（Stockholder's Equity） |
861,294,507.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,472,759,432.96 |
